rs12232780
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001387283.1(SMARCA4):c.2617-321G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 440,446 control chromosomes in the GnomAD database, including 18,525 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 4941 hom., cov: 33)
Exomes 𝑓: 0.30 ( 13584 hom. )
Consequence
SMARCA4
NM_001387283.1 intron
NM_001387283.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.325
Publications
25 publications found
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-11021404-G-A is Benign according to our data. Variant chr19-11021404-G-A is described in ClinVar as [Benign]. Clinvar id is 1249450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2617-321G>A | intron_variant | Intron 18 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.2617-321G>A | intron_variant | Intron 18 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.2617-321G>A | intron_variant | Intron 18 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.2617-321G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.2617-321G>A | intron_variant | Intron 18 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.2617-321G>A | intron_variant | Intron 18 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.2617-321G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000643995.1 | c.2029-321G>A | intron_variant | Intron 15 of 31 | ENSP00000496004.1 | |||||
SMARCA4 | ENST00000644963.1 | c.1261-321G>A | intron_variant | Intron 11 of 27 | ENSP00000495599.1 | |||||
SMARCA4 | ENST00000644065.1 | c.1342-321G>A | intron_variant | Intron 11 of 26 | ENSP00000493615.1 | |||||
SMARCA4 | ENST00000642350.1 | c.1102-321G>A | intron_variant | Intron 10 of 26 | ENSP00000495355.1 | |||||
SMARCA4 | ENST00000643857.1 | c.970-321G>A | intron_variant | Intron 9 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.237 AC: 36013AN: 152066Hom.: 4943 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
36013
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.297 AC: 85670AN: 288262Hom.: 13584 Cov.: 0 AF XY: 0.305 AC XY: 46840AN XY: 153512 show subpopulations
GnomAD4 exome
AF:
AC:
85670
AN:
288262
Hom.:
Cov.:
0
AF XY:
AC XY:
46840
AN XY:
153512
show subpopulations
African (AFR)
AF:
AC:
738
AN:
8784
American (AMR)
AF:
AC:
3060
AN:
17064
Ashkenazi Jewish (ASJ)
AF:
AC:
2789
AN:
8730
East Asian (EAS)
AF:
AC:
3305
AN:
15850
South Asian (SAS)
AF:
AC:
17109
AN:
46850
European-Finnish (FIN)
AF:
AC:
4499
AN:
13224
Middle Eastern (MID)
AF:
AC:
803
AN:
2344
European-Non Finnish (NFE)
AF:
AC:
48810
AN:
159624
Other (OTH)
AF:
AC:
4557
AN:
15792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3165
6331
9496
12662
15827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.237 AC: 36013AN: 152184Hom.: 4941 Cov.: 33 AF XY: 0.241 AC XY: 17900AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
36013
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
17900
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
3807
AN:
41546
American (AMR)
AF:
AC:
2965
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
1134
AN:
3470
East Asian (EAS)
AF:
AC:
1129
AN:
5178
South Asian (SAS)
AF:
AC:
1664
AN:
4826
European-Finnish (FIN)
AF:
AC:
3667
AN:
10584
Middle Eastern (MID)
AF:
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20786
AN:
67966
Other (OTH)
AF:
AC:
516
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1387
2774
4161
5548
6935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
928
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.